LIC raises stake in Sun Pharma to 5 04%
Traducteur pour Néerlandais et Français The company invested ₹1685.5 crore in research and development, which is 6% of the overall sales. With this, LIC’s stake in the blue-chip pharma stock has jumped to 5.004% from 4.996% earlier. Check the score based on the company’s fundamentals, solvency, growth, risk & ownership to decide the right stocks. Suzlon shares: FIIs up their bet as desi investors cut stake in Q3; check preview, targets India’s largest hospitality company by market capitalization, the IHCL…